SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS
The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FERRARA, Steven, James MCKINNEY, David MORTIER, Jérémie LEMOS, Clara SHEKHAR, Mrinal CHRISTIAN, Sven BÖMER, Ulf LECHNER, Christian CORSELLO, Steven KAULFUSS, Stefan RUPAIMOOLE, Rajesha WAGNER, Florence, F SCHULZE, Volker HANDING, Katarzyna MENGEL, Anne LIENAU, Philip BRZEZINKA, Krzysztof ORSI, Douglas HILLIG, Roman BERGER, Markus |
| description | The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4469457A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4469457A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4469457A13</originalsourceid><addsrcrecordid>eNrjZNAMDnUKDvEMCQ1xdVHwcA1xDfJ3jnT28XRWcA728zZU8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASYmZpYmpuaOhsZEKAEADbAkXw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS</title><source>esp@cenet</source><creator>FERRARA, Steven, James ; MCKINNEY, David ; MORTIER, Jérémie ; LEMOS, Clara ; SHEKHAR, Mrinal ; CHRISTIAN, Sven ; BÖMER, Ulf ; LECHNER, Christian ; CORSELLO, Steven ; KAULFUSS, Stefan ; RUPAIMOOLE, Rajesha ; WAGNER, Florence, F ; SCHULZE, Volker ; HANDING, Katarzyna ; MENGEL, Anne ; LIENAU, Philip ; BRZEZINKA, Krzysztof ; ORSI, Douglas ; HILLIG, Roman ; BERGER, Markus</creator><creatorcontrib>FERRARA, Steven, James ; MCKINNEY, David ; MORTIER, Jérémie ; LEMOS, Clara ; SHEKHAR, Mrinal ; CHRISTIAN, Sven ; BÖMER, Ulf ; LECHNER, Christian ; CORSELLO, Steven ; KAULFUSS, Stefan ; RUPAIMOOLE, Rajesha ; WAGNER, Florence, F ; SCHULZE, Volker ; HANDING, Katarzyna ; MENGEL, Anne ; LIENAU, Philip ; BRZEZINKA, Krzysztof ; ORSI, Douglas ; HILLIG, Roman ; BERGER, Markus</creatorcontrib><description>The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241204&DB=EPODOC&CC=EP&NR=4469457A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241204&DB=EPODOC&CC=EP&NR=4469457A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FERRARA, Steven, James</creatorcontrib><creatorcontrib>MCKINNEY, David</creatorcontrib><creatorcontrib>MORTIER, Jérémie</creatorcontrib><creatorcontrib>LEMOS, Clara</creatorcontrib><creatorcontrib>SHEKHAR, Mrinal</creatorcontrib><creatorcontrib>CHRISTIAN, Sven</creatorcontrib><creatorcontrib>BÖMER, Ulf</creatorcontrib><creatorcontrib>LECHNER, Christian</creatorcontrib><creatorcontrib>CORSELLO, Steven</creatorcontrib><creatorcontrib>KAULFUSS, Stefan</creatorcontrib><creatorcontrib>RUPAIMOOLE, Rajesha</creatorcontrib><creatorcontrib>WAGNER, Florence, F</creatorcontrib><creatorcontrib>SCHULZE, Volker</creatorcontrib><creatorcontrib>HANDING, Katarzyna</creatorcontrib><creatorcontrib>MENGEL, Anne</creatorcontrib><creatorcontrib>LIENAU, Philip</creatorcontrib><creatorcontrib>BRZEZINKA, Krzysztof</creatorcontrib><creatorcontrib>ORSI, Douglas</creatorcontrib><creatorcontrib>HILLIG, Roman</creatorcontrib><creatorcontrib>BERGER, Markus</creatorcontrib><title>SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS</title><description>The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAMDnUKDvEMCQ1xdVHwcA1xDfJ3jnT28XRWcA728zZU8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASYmZpYmpuaOhsZEKAEADbAkXw</recordid><startdate>20241204</startdate><enddate>20241204</enddate><creator>FERRARA, Steven, James</creator><creator>MCKINNEY, David</creator><creator>MORTIER, Jérémie</creator><creator>LEMOS, Clara</creator><creator>SHEKHAR, Mrinal</creator><creator>CHRISTIAN, Sven</creator><creator>BÖMER, Ulf</creator><creator>LECHNER, Christian</creator><creator>CORSELLO, Steven</creator><creator>KAULFUSS, Stefan</creator><creator>RUPAIMOOLE, Rajesha</creator><creator>WAGNER, Florence, F</creator><creator>SCHULZE, Volker</creator><creator>HANDING, Katarzyna</creator><creator>MENGEL, Anne</creator><creator>LIENAU, Philip</creator><creator>BRZEZINKA, Krzysztof</creator><creator>ORSI, Douglas</creator><creator>HILLIG, Roman</creator><creator>BERGER, Markus</creator><scope>EVB</scope></search><sort><creationdate>20241204</creationdate><title>SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS</title><author>FERRARA, Steven, James ; MCKINNEY, David ; MORTIER, Jérémie ; LEMOS, Clara ; SHEKHAR, Mrinal ; CHRISTIAN, Sven ; BÖMER, Ulf ; LECHNER, Christian ; CORSELLO, Steven ; KAULFUSS, Stefan ; RUPAIMOOLE, Rajesha ; WAGNER, Florence, F ; SCHULZE, Volker ; HANDING, Katarzyna ; MENGEL, Anne ; LIENAU, Philip ; BRZEZINKA, Krzysztof ; ORSI, Douglas ; HILLIG, Roman ; BERGER, Markus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4469457A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FERRARA, Steven, James</creatorcontrib><creatorcontrib>MCKINNEY, David</creatorcontrib><creatorcontrib>MORTIER, Jérémie</creatorcontrib><creatorcontrib>LEMOS, Clara</creatorcontrib><creatorcontrib>SHEKHAR, Mrinal</creatorcontrib><creatorcontrib>CHRISTIAN, Sven</creatorcontrib><creatorcontrib>BÖMER, Ulf</creatorcontrib><creatorcontrib>LECHNER, Christian</creatorcontrib><creatorcontrib>CORSELLO, Steven</creatorcontrib><creatorcontrib>KAULFUSS, Stefan</creatorcontrib><creatorcontrib>RUPAIMOOLE, Rajesha</creatorcontrib><creatorcontrib>WAGNER, Florence, F</creatorcontrib><creatorcontrib>SCHULZE, Volker</creatorcontrib><creatorcontrib>HANDING, Katarzyna</creatorcontrib><creatorcontrib>MENGEL, Anne</creatorcontrib><creatorcontrib>LIENAU, Philip</creatorcontrib><creatorcontrib>BRZEZINKA, Krzysztof</creatorcontrib><creatorcontrib>ORSI, Douglas</creatorcontrib><creatorcontrib>HILLIG, Roman</creatorcontrib><creatorcontrib>BERGER, Markus</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FERRARA, Steven, James</au><au>MCKINNEY, David</au><au>MORTIER, Jérémie</au><au>LEMOS, Clara</au><au>SHEKHAR, Mrinal</au><au>CHRISTIAN, Sven</au><au>BÖMER, Ulf</au><au>LECHNER, Christian</au><au>CORSELLO, Steven</au><au>KAULFUSS, Stefan</au><au>RUPAIMOOLE, Rajesha</au><au>WAGNER, Florence, F</au><au>SCHULZE, Volker</au><au>HANDING, Katarzyna</au><au>MENGEL, Anne</au><au>LIENAU, Philip</au><au>BRZEZINKA, Krzysztof</au><au>ORSI, Douglas</au><au>HILLIG, Roman</au><au>BERGER, Markus</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS</title><date>2024-12-04</date><risdate>2024</risdate><abstract>The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4469457A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FERRARA,%20Steven,%20James&rft.date=2024-12-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4469457A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |